CA2345767A1 - Therapy for improving cognition - Google Patents
Therapy for improving cognition Download PDFInfo
- Publication number
- CA2345767A1 CA2345767A1 CA002345767A CA2345767A CA2345767A1 CA 2345767 A1 CA2345767 A1 CA 2345767A1 CA 002345767 A CA002345767 A CA 002345767A CA 2345767 A CA2345767 A CA 2345767A CA 2345767 A1 CA2345767 A1 CA 2345767A1
- Authority
- CA
- Canada
- Prior art keywords
- atypical antipsychotic
- patients suffering
- acetylcholinesterase inhibitor
- alzheimer
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98203454.8 | 1998-10-16 | ||
EP98203454 | 1998-10-16 | ||
PCT/EP1999/007804 WO2000023057A2 (en) | 1998-10-16 | 1999-10-12 | Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2345767A1 true CA2345767A1 (en) | 2000-04-27 |
Family
ID=8234219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002345767A Abandoned CA2345767A1 (en) | 1998-10-16 | 1999-10-12 | Therapy for improving cognition |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1121131A2 (sk) |
JP (1) | JP2002527469A (sk) |
KR (1) | KR20010072878A (sk) |
CN (1) | CN1367697A (sk) |
AU (1) | AU6472799A (sk) |
BG (1) | BG105302A (sk) |
BR (1) | BR9914419A (sk) |
CA (1) | CA2345767A1 (sk) |
EE (1) | EE200100136A (sk) |
HK (1) | HK1039745A1 (sk) |
HR (1) | HRP20010262A2 (sk) |
HU (1) | HUP0103781A3 (sk) |
ID (1) | ID28441A (sk) |
IL (1) | IL142588A0 (sk) |
NO (1) | NO20011403L (sk) |
PL (1) | PL348107A1 (sk) |
SK (1) | SK4592001A3 (sk) |
TR (1) | TR200101082T2 (sk) |
WO (1) | WO2000023057A2 (sk) |
ZA (1) | ZA200103081B (sk) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
WO2003037337A1 (en) * | 2001-10-30 | 2003-05-08 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
US20050232990A1 (en) * | 2003-12-31 | 2005-10-20 | Garth Boehm | Donepezil formulations |
JP2008523058A (ja) * | 2004-12-10 | 2008-07-03 | アボット・ラボラトリーズ | 縮合ビシクロ複素環置換キヌクリジン誘導体 |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
EP2091948B1 (en) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
CN102905532A (zh) | 2010-02-09 | 2013-01-30 | 约翰斯.霍普金斯大学 | 用于改善认知功能的方法和组合物 |
ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
EA034167B8 (ru) | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
EP0515301A3 (en) * | 1991-05-14 | 1993-06-16 | Ernir Snorrason | Improvements in benzodiazepine treatment by cholinesterterase inhibitors |
JP4640888B2 (ja) * | 1997-08-11 | 2011-03-02 | ザ ユニヴァーシティー オブ サウス フロリダ | 神経精神性疾患用ニコチンアンタゴニスト |
RU2219924C2 (ru) * | 1998-04-14 | 2003-12-27 | Дзе Дженерал Хоспитал Корпорейшн | Способ лечения нейропсихиатрических расстройств |
-
1999
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Application Discontinuation
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Application Discontinuation
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-10 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
-
2002
- 2002-01-10 HK HK02100158.6A patent/HK1039745A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1121131A2 (en) | 2001-08-08 |
PL348107A1 (en) | 2002-05-06 |
SK4592001A3 (en) | 2001-12-03 |
BR9914419A (pt) | 2001-06-26 |
EE200100136A (et) | 2002-06-17 |
TR200101082T2 (tr) | 2001-09-21 |
HRP20010262A2 (en) | 2002-06-30 |
ID28441A (id) | 2001-05-24 |
WO2000023057A3 (en) | 2000-07-27 |
AU6472799A (en) | 2000-05-08 |
HUP0103781A2 (hu) | 2002-03-28 |
IL142588A0 (en) | 2002-03-10 |
BG105302A (en) | 2001-11-30 |
KR20010072878A (ko) | 2001-07-31 |
CN1367697A (zh) | 2002-09-04 |
HK1039745A1 (zh) | 2002-05-10 |
NO20011403D0 (no) | 2001-03-20 |
JP2002527469A (ja) | 2002-08-27 |
ZA200103081B (en) | 2002-07-12 |
NO20011403L (no) | 2001-03-20 |
WO2000023057A2 (en) | 2000-04-27 |
HUP0103781A3 (en) | 2003-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2345767A1 (en) | Therapy for improving cognition | |
RU93004484A (ru) | Производные пиразола, способ их получения и содержащие их фармацевтические композиции | |
YU66600A (sh) | Farmaceutski preparati koji mogu da budu gelirani | |
IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
US6291471B1 (en) | Use of apomorphine for the treatment of organic erectile dysfunction in males | |
JP2001523715A (ja) | 脂肪酸のコリンエステル及び脳卒中の治療におけるそれらの使用 | |
MD1699F2 (ro) | Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei | |
CA2433585A1 (en) | Pharmaceutical compositions containing donepezil hydrochloride | |
DE69431433D1 (de) | Zusammensetzungen und verfahren zur reparatur und vorbeugung fibrotischer verletzungen | |
MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
JP2019510039A5 (sk) | ||
CA2378613A1 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
CN1317030C (zh) | 用中等剂量的lhrh拮抗剂治疗阿尔茨海默氏病 | |
HUT61743A (en) | Process for producing 2-(piperidin-1-yl)-ethanol derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
KR20060130619A (ko) | 유기 화합물의 조합물 | |
HUP0102987A3 (en) | Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
JP4135263B2 (ja) | クリーム状洗浄剤組成物 | |
CA2590224A1 (en) | Method for reduction, stabilization and prevention of rupture of lipid rich plaque | |
JPH0678227B2 (ja) | 4−エチル−2−ヒドロキシイミノ−5−ニトロ−3−ヘキセンアミド含有製剤用の安定化剤、安定化方法及び安定化された製剤 | |
EP0671908B1 (en) | Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers | |
CA1209047A (en) | Therapeutic composition containing piracetam analog | |
JP2004123558A (ja) | 片頭痛の予防、治療剤 | |
NZ321370A (en) | Polymorphic forms of a growth hormone secretagogue | |
MXPA02012957A (es) | Formulacion nueva. | |
RU2001113270A (ru) | Лечение, направленное на улучшение познавательной способности |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |